Cargando…
Fecal elastase, an assay for exocrine pancreatic insufficiency, has clinical utility in patients with pancreatic ductal adenocarcinoma
Autores principales: | Gong, Jun, Guan, Michelle, Forsmark, Christopher E., Petzel, Maria Q., Placencio-Hickok, Veronica, Hendifar, Andrew |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7734497/ https://www.ncbi.nlm.nih.gov/pubmed/33354227 http://dx.doi.org/10.1177/1756284820964319 |
Ejemplares similares
-
Prevalence of Exocrine Pancreatic Insufficiency in Women with Obesity Syndrome: Assessment by Pancreatic Fecal Elastase 1
por: Teichmann, J., et al.
Publicado: (2011) -
Update on the diagnosis and management of exocrine pancreatic insufficiency
por: Perbtani, Yaseen, et al.
Publicado: (2019) -
Endoscopic Ultrasound Findings in Patients Diagnosed with Exocrine Pancreatic Insufficiency by Low Fecal Elastase-1
por: Shobassy, Mazen, et al.
Publicado: (2019) -
Prevalence of Radiological Chronic Pancreatitis and Exocrine Pancreatic Insufficiency in Patients with Decompensated Liver Disease: Is Fecal Elastase Useful in This Setting?
por: Llibre-Nieto, Gemma, et al.
Publicado: (2023) -
Challenges in Diagnosis and Treatment of Pancreatic Exocrine Insufficiency among Patients with Pancreatic Ductal Adenocarcinoma
por: Lan, Xiaoyang, et al.
Publicado: (2023)